Journal of the Faculty of Medicine Baghdad’s Post

Featured Research article from our latest JFMB 2nd issue Vol.66 concludes CXCL 9 may be employed as a biomarker for identifying ulcerative colitis and it can be used as a tool for measuring disease activity, in addition to the possibility of being a potential therapeutic target. https://lnkd.in/e_i5NqEu

Discover the KL-6 biomarker in our new product leaflet! Serum KL-6 is the most sensitive and specific serum marker of interstitial lung disease (ILD) that accurately reflects the severity of ILD and its fibrosis progression. Moreover, fluctuations of serum KL-6 levels serve as a reliable predictor of mortality in patients experiencing acute exacerbations of ILD and in those diagnosed with idiopathic pulmonary fibrosis (IPF). Read more about the Krebs von den Lungen-6 (KL-6) biomarker in the new leaflet below. In case of any questions you can always contact our Head of Sales Lenka Sochorová and Business development Specialist Erik Nomilner. #BioVendorGroup #lungs #lunghealth #pulmonaryfibrosis #diagnostics

Cancer care is a realm marked by constant challenges, changes, and the eternal hope of eradication. Harnessing next-generation #biomarkers and personalized assessments, we're reshaping early detection, diagnosis, and monitoring strategies. Learn more: https://lnkd.in/g_DUQxWa #BiomarkerDrivenTherapies #Oncology #PrecisionMedicine

#Biomarker testing can help those facing #OvarianCancer better understand their treatment options. As we continue to make progress in the fight against this disease, ensuring awareness and understanding of new developments around #biomarkers can help doctors and patients determine the most appropriate treatment plan. Join us in raising the volume about biomarkers during #OvarianCancerAwarenessMonth: https://lnkd.in/gdAYKPrP

On this World Lung Day, we would like to emphasize the importance of Krebs von den Lungen-6 (#KL-6) as a key biomarker for interstitial pneumonia. KL-6, a high molecular weight glycoprotein, is a reliable serum biomarker for interstitial lung diseases (ILD). It plays a key role in diagnosis, monitoring disease activity, evaluating treatment response, and predicting clinical outcomes. Due to the complexity of ILD, patients are frequently misdiagnosed, which could lead to delays in appropriate management #WorldLungDay #Lung #laboratory #laboratoryequipment #diagnosis

A measurable trait in the body that suggests the presence of disease is called a biomarker. In fact, several biomarkers can gauge a disease's level of progression. Historically, there were no biomarkers for Parkinson’s Disease. However, over the last few years, new developments on biomarkers and PD have been made and APDA wants you to be informed. To learn more watch Spotlight on Parkinson's Disease where Dr. David Standaert explains how PD is diagnosed and the biomarkers of PD. https://lnkd.in/e-4mEWNa #Parkinsons #PDResearch #Spotlight #Biomarkers

🚀 Revolutionizing Disease Diagnosis with TRACE-E: A Breakthrough in Breath Analysis 🫁 An accurate diagnosis is critical for patient outcomes. We believe TRACE-E will have a profound impact, providing non-invasive, real-time analysis of breath biomarkers linked to disease onset. Read on to learn more about TRACE-E and how it is differentiated from other diagnostic options. #InnovationInHealthcare #BreathBasedDiagnostics #DiseaseDiagnosis #Biomarkers #HealthcareInnovation #MedTech

We’re excited to partner with Agilent Technologies to present Decode Health’s RNA biomarker discovery framework to uncover reliable biomarkers to detect, monitor, and treat disease. This webinar will discuss implementing a multifaceted quality control plan to optimize your design and boost confidence in your findings. Please join Cheryl Sesler, MS, Associate Director of Research at Decode, and Dr. Annika Dorn at Agilent by registering at the link below! Tuesday, June 18 at 11:00AM EST Link to register: https://bit.ly/3UB3MkK #RNAsequencing #RNAseq #BiomarkerDiscovery #Transcriptomics #Diagnostics #Therapeutics #Biomarkers #NextGenSequencing #QualityControl #webinar

At Trace Sensing, we believe in pushing against preconceived limits and challenging the status quo! TRACE-E is here to bring our innovative approach to healthcare and prioritize accurate, effective, and patient-forward diagnosis as the new standard for medical devices. Follow Trace Sensing Technologies to learn about TRACE-E and why other diagnostic options should take notice. 👀 #singlemolecule #realtime #biologicallyrelevant #costeffective #fundamentalbiology

#WorldThyroidDay According to data from the WHO, thyroid disease affects over 300 million people worldwide and has become one of the most common diseases in the endocrine system. Although thyroid diseases are not as leading causes of death globally as cancer, their impact on quality of life cannot be ignored, often leading to misdiagnosis or delayed treatment due to hidden symptoms. Early detection and intervention can not only simplify the treatment process, but also greatly reduce the physical and mental burden and economic pressure on patients. C-Luminary Biotech can provide comprehensive thyroid function biomarker detection items to assist in early clinical diagnosis and treatment. #IVD #immunodiagnosis #chemiluminescence #assay #diagnostics #CLIA #hospital #biotech #cluminary #sharay1600 #sharetrybio